Friday, 6 November 2026

Ghana’s news, on the hourWork with us

Friday, 6 November 2026

Accra—:—London—:—New York—:—Beijing—:—

Ghanaian press · Organization

National Vaccine Institute

Also known as: NVI

National Vaccine Institute — Ghana's vaccine development and manufacturing agency, leading establishment of mRNA laboratory capacity and local vaccine production initiatives.

2026-04-272026-11-06

News reports

Order a long-term news report on National Vaccine Institute

Every mention in the Ghanaian press over the period you choose, compiled as a PDF or Word document.

In coverage

Verbatim sentences from the source article.

September 2026
22 SeptThe Ghanaian Times
… On domestic vaccine production, Mr Atasige urged the government to accelerate local manufacturing and regional procurement through the National Vaccine Institute to reduce dependence on external financing and strengthen the country’s preparedness. …
Finance immunisation ahead of GAVI exit — Stakeholders
10 SeptJoy Online
Chief Executive Officer of the National Vaccine Institute (NVI), Dr Sodzi Sodzi-Tettey, has disclosed that Ghana is preparing to pre-qualify Ghanaian companies to manufacture vaccines for the local and wider African market. …
Ghana to pre-qualify local companies to manufacture vaccines for African market
7 SeptJoy Online
… According to the National Vaccine Institute (NVI), the arrangement will create expanded and more predictable demand for African-made products. …
Ghana moves to become Africa’s vaccine and pharmaceutical manufacturing hub
7 SeptJoy Online
… The National Vaccine Institute (NVI) says the mechanism could help address one of the major constraints facing local manufacturers: the limited size of Ghana’s domestic market. …
Ghanaian vaccine makers gain access to 1.4bn African market under new deal
August 2026
27 AugJoy Online
… The pilot, led in Ghana by the National Vaccine Institute (NVI), is intended to help institutions identify strengths and capacity gaps in the systems needed to support ethical, efficient and scientifically rigorous clinical research. …
Ghana among 8 countries selected to pilot WHO tool for stronger clinical trial systems
24 AugJoy Online
… The initiative is jointly funded by the German Federal Ministry for Economic Cooperation and Development and the European Union and implemented by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), in collaboration with Ghana’s National Vaccine Institute. …
€2m boost for Ghana pharmaceutical research and vaccine innovation
20 AugJoy Online
… The grants were presented at a Research Meets Manufacturing award ceremony in Accra on 19 August, co-hosted by the National Vaccine Institute (NVI) and the German development agency GIZ. …
Eight projects win €2m Ghana grants for vaccine and drug research
17 AugJoy Online
… t burden on the country’s health financing system and could affect the availability and affordability of medicines for patients. “Something very important happened in my office two days ago,” President Mahama said, explaining that representatives of the National Vaccine Institute …
Mahama says Ghana will reduce 70% medicine import dependence under five-year plan
17 AugJoy Online
… He said the plan had been presented to him by the National Vaccine Institute, the Ministry of Health, the Pharmaceutical Association of Ghana and other allied institutions. …
Ghana to expand pharmaceutical manufacturing capacity – Mahama
14 AugJoy Online
… He said the plan had been presented to him by the National Vaccine Institute, the Ministry of Health, the Pharmaceutical Association of Ghana and other allied institutions. …
Mahama announces five-year plan to cut Ghana’s reliance on imported medicines

Business

Ghana launches policy to reduce medicine import dependence

The News

Ghana has approved the Ghana Pharmaceutical Manufacturing Policy, aiming to reverse the country's 70 per cent dependence on imported medicines by building a sustainable, competitive and integrated pharmaceutical ecosystem. The policy, launched on October 28, addresses longstanding challenges including access to finance, infrastructure and raw materials as part of efforts to position Ghana as a pharmaceutical manufacturing hub in Africa.

2 November 2026 · Joy Online →

Monday 2 November

Ghana launches policy to reduce medicine import dependence
Ghana has approved the Ghana Pharmaceutical Manufacturing Policy, aiming to reverse the country's 70 per cent dependence on imported medicines by building a sustainable, competitive and integrated pharmaceutical ecosystem. The policy, launched on October 28, addresses longstanding challenges including access to finance, infrastructure and raw materials as part of efforts to position Ghana as a pharmaceutical manufacturing hub in Africa.
2 November 2026 · Joy Online →

Thursday 29 October

Ghana launches policy to double local pharmaceutical manufacturing
The government has launched the Cabinet-approved Ghana Pharmaceutical Manufacturing Policy to double domestic medicine production, address dependence on imports (which account for 70% of medicine supply), and increase locally manufactured medicines' share of the domestic market from 30% to 60%. The policy, announced by the Trade Minister, provides a coordinated framework covering investment, regulation, public procurement, skills development, and regional trade.
29 October 2026 · Joy Online →
Ghana launches pharmaceutical policy to advance vaccine manufacturing
Ghana's National Vaccine Institute CEO declared the pharmaceutical industry has entered a "golden era" as the government launched the Ghana Pharmaceutical Manufacturing Policy on October 28, 2026, aimed at transforming Ghana into a continental hub for medicine and vaccine manufacturing. The policy addresses financing challenges facing local manufacturers, including support for private manufacturers Atlantic Lifesciences and DEK Vaccines Ltd, which require at least $100 million to build and equip their plants.
29 October 2026 · Joy Online →
Ghana joins five African nations with mRNA vaccine laboratory
The National Vaccine Institute has established a state-of-the-art mRNA laboratory at the Noguchi Memorial Institute for Medical Research, making Ghana one of only five African countries with this technology. The facility, to be launched by President Mahama this year, positions Ghana to develop and manufacture vaccines locally rather than relying on imports.
29 October 2026 · Joy Online →

Friday 9 October

NVI CEO defends GH¢13m spending on training and workshops
The National Vaccine Institute's CEO has defended the Institute's GH¢13 million expenditure on training, workshops and conferences in 2025, arguing the spending supports development of Ghana's vaccine manufacturing sector by building capacity among researchers, manufacturers and regulators. The defence comes after the Auditor-General reported the Institute moved from a GH¢36 million profit to a GH¢21 million loss within the financial year.
9 October 2026 · Joy Online →
Ghana to manufacture tetanus-diphtheria vaccine by 2027
Ghana is expected to produce its first locally manufactured vaccine—a tetanus-diphtheria vaccine—by 2027 through Atlantic Lifesciences Limited, with production supported by a partnership involving local institutions, private manufacturers, and an Indonesian pharmaceutical company. The National Vaccine Institute has completed a technology transfer agreement with Indonesia to reduce Ghana's reliance on imported vaccines.
9 October 2026 · Joy Online →

Wednesday 7 October

Minister calls for unified biotech regulations to boost investment
The Minister of Environment, Science and Technology said regulatory uncertainty discourages investment in Ghana's biotechnology sector and called for harmonised frameworks to provide clarity. She urged Ghana to transition from using biotechnology products to producing and developing its own technologies.
7 October 2026 · The Ghanaian Times →

Sunday 4 October

Mahama urges African leaders to prioritise health sovereignty
President Mahama has called on African leaders to treat health as an investable, high-growth economic sector rather than a charitable cost, positioning health sovereignty and economic security of Africa's 1.4 billion people as a continental priority.
4 October 2026 · Joy Online →

Saturday 3 October

Mahama urges African leaders to prioritize health sovereignty
At the Alamein Africa Forum in Egypt, President Mahama called on African leaders to make health sovereignty a priority for the continent's 1.4 billion people, arguing that health should be treated as an investable, high-growth economic sector rather than a charitable cost. He cited evidence that investment in basic maternal and newborn care yields significant economic returns for every dollar invested.
3 October 2026 · Joy Online →
Mahama outlines Ghana's healthcare expansion and local medicine production plans
President Mahama has outlined Ghana's "Accra Reset" strategy to expand healthcare access and develop local capacity to produce medicines, vaccines and health products. The agenda includes expanding the National Health Insurance Scheme, introducing Free Primary Health Care, establishing the Ghana Medical Trust Fund, and empowering the Food and Drugs Authority and National Vaccine Institute to shift Ghana from a consumer to a producer of health products.
3 October 2026 · Joy Online →

Tuesday 22 September

Stakeholders urge government financing for immunisation before GAVI exit
Health-sector stakeholders have called on the government to fully finance immunisation interventions ahead of Ghana's planned exit from GAVI in 2030, warning that delaying action until the transition deadline could undermine gains in child health. Ghana is in the "Accelerated Transition Phase" and has less than four years to prepare for complete transition by January 2030.
22 September 2026 · The Ghanaian Times →

Thursday 10 September

Ghana to pre-qualify local vaccine manufacturers for African market
The CEO of Ghana's National Vaccine Institute said the country is preparing to pre-qualify Ghanaian companies to manufacture vaccines for local and wider African markets, following Ghana's decision to join the Africa Pool Procurement Mechanism. A regional meeting is planned for November in Accra to launch an application process for assessing and pre-qualifying eligible companies.
10 September 2026 · Joy Online →

Monday 7 September

Ghana signs agreement to boost vaccine and pharmaceutical manufacturing
Ghana has signed a Memorandum of Understanding on August 21, 2026, to participate in the African Pooled Procurement Mechanism, giving Ghanaian pharmaceutical and vaccine manufacturers access to a larger continental market and creating more predictable demand for locally manufactured health products.
7 September 2026 · Joy Online →
Ghanaian vaccine makers gain continental market access via Africa CDC deal
Ghana has signed a Memorandum of Understanding with the Africa Centres for Disease Control and Prevention to join the African Pooled Procurement Mechanism, granting Ghanaian vaccine and pharmaceutical manufacturers access to a market of about 1.4 billion people across all 55 African Union member states.
7 September 2026 · Joy Online →

Thursday 27 August

Ghana pilots WHO benchmarking tool for clinical trial systems
Ghana has been selected as one of eight countries worldwide to pilot a WHO benchmarking tool designed to assess and strengthen institutional capacity for conducting high-quality clinical trials. The tool examines seven functional areas across 32 objectives and 112 outcomes, and 13 Ghanaian institutions participated in an assessment exercise.
27 August 2026 · Joy Online →

Monday 24 August

Ghana receives €2 million for pharmaceutical research and vaccine innovation
Eight Ghanaian research institutions and pharmaceutical companies have been awarded €2 million in grants under the PharmaVax Ghana programme to develop vaccines, medicines, and health products. The projects, jointly funded by Germany and the EU and implemented by GIZ, cover innovations in malaria treatment, monoclonal antibodies, diagnostics, and herbal remedies for various conditions.
24 August 2026 · Joy Online →

Thursday 20 August

Eight research partnerships awarded €2m for vaccine and drug development
Eight research partnerships have been awarded €2m in grants under the PharmaVax Ghana programme to develop new vaccines and medicines, including child-friendly malaria medicines, plant-based therapies, and AI-assisted antibody discovery for malaria and Mpox. The programme, funded by Germany and the EU, will also provide technical assistance to help researchers commercialise health products for local and regional markets.
20 August 2026 · Joy Online →

Monday 17 August

Ghana pursues five-year plan to reduce medicine import dependence
President Mahama announced a five-year strategic plan to strengthen pharmaceutical manufacturing and reduce Ghana's reliance on imported medicines, with the goal of achieving self-sufficiency in essential drug production and positioning Ghana as a regional supply hub. The plan aims to address Ghana's current dependence on imports for approximately 70 percent of medicines used in the country.
17 August 2026 · Joy Online →
Ghana plans to expand pharmaceutical manufacturing to reduce imports
President Mahama announced plans to expand Ghana's pharmaceutical manufacturing capacity with a five-year government plan aimed at reducing dependence on imported medicines, which currently account for about 70 per cent of medicines used in Ghana. The expansion is intended to reduce medicine costs, strengthen the provision of treatment under the Free Primary Health Care programme, and create export opportunities to neighbouring countries.
17 August 2026 · Joy Online →

Friday 14 August

Mahama outlines five-year plan to boost local medicine production
President Mahama announced a five-year plan to expand Ghana's pharmaceutical manufacturing capacity and reduce reliance on imported medicines, which currently account for 70 per cent of drugs used in the country. The plan, presented by the National Vaccine Institute, Ministry of Health, and Pharmaceutical Association of Ghana, aims to lower medicine costs and enable export to neighbouring countries.
14 August 2026 · Joy Online →

Thursday 6 August

UHAS to establish AI Centre of Excellence for healthcare research
The University of Health and Allied Sciences plans to establish an AI Centre of Excellence focused on research, innovation and capacity building in healthcare. The centre will conduct research on clinical trials, drug development, sustainable health financing and health leadership, and will train health professionals and students from tertiary institutions.
6 August 2026 · Daily Guide →

Wednesday 22 July

Africa must strengthen domestic health financing, Deputy Health Minister says
Deputy Minister of Health Professor Grace Ayensu-Danquah called on African countries to increase domestic health financing as external donor support becomes less certain, noting that official development assistance and long-standing funding models are changing and programmes many health systems have relied on can no longer be taken for granted.
22 July 2026 · Joy Online →

Friday 17 July

UHAS laboratory complex project over 70 percent complete
President Mahama has announced that the University of Health and Allied Sciences is set to house one of West Africa's largest laboratory complexes upon completion of an ongoing laboratory block project, which is now more than 70 percent complete and will boost medical education, research, and vaccine development in Ghana.
17 July 2026 · Joy Online →
UHAS laboratory complex over 70 percent complete, Mahama says
President Mahama announced that UHAS is on course to house one of the largest laboratory complexes in West Africa upon completion of an ongoing laboratory block project that is now more than 70 percent complete. The facility is expected to boost medical education, research, and vaccine development in Ghana and strengthen the university's international standing.
17 July 2026 · Joy Online →
New UHAS laboratory complex to advance Ghana's health research capacity
President John Dramani Mahama has inaugurated a newly completed laboratory complex at the University of Health and Allied Sciences, describing it as a strategic investment that will strengthen Ghana's scientific research ecosystem and advance vaccine development, disease surveillance, and health innovation capabilities.
17 July 2026 · The Chronicle →
New UHAS laboratory complex to advance Ghana's health research
President Mahama has opened a newly completed laboratory complex at the University of Health and Allied Sciences, which he says will strengthen Ghana's scientific research ecosystem and advance vaccine development, disease surveillance, and health innovation.
17 July 2026 · The Chronicle →

Friday 12 June

Ghanaians support government vaccine manufacturing initiative
Many Ghanaians have welcomed government plans to establish local vaccine manufacturing through the National Vaccine Institute, with respondents expressing support for the move as a way to strengthen health security, improve vaccine access, and reduce import dependence. Respondents cited confidence in Ghana's health professionals and called for regulatory bodies to maintain quality standards.
12 June 2026 · Joy Online →

Wednesday 10 June

Northern Region leaders support Ghana vaccine manufacturing plan
Local leaders in Ghana's Northern Region have expressed support for the country's plan to locally manufacture vaccines through a proposed National Vaccine Institute, while raising concerns over quality assurance, public trust, and equitable access to vaccination services. They say the initiative could strengthen Ghana's health security and reduce dependence on imported vaccines if properly implemented, but emphasize that success depends on strict quality control, professional training, and proper storage systems.
10 June 2026 · Joy Online →
Northern Region leaders support Ghana vaccine production plan
Local leaders in Ghana's Northern Region have expressed support for the government's plan to locally manufacture vaccines through a proposed National Vaccine Institute, citing potential to strengthen health security and reduce imported vaccine dependence, but they have raised concerns over quality assurance, public trust, and equitable access to vaccination services.
10 June 2026 · Joy Online →

Friday 5 June

NVI seeks investors for local vaccine manufacturing by 2030
Ghana's National Vaccine Institute is seeking partnerships with investors including Ghana Exim Bank, Afreximbank, and the International Finance Corporation to fund local vaccine manufacturers, as GAVI funding ends in 2030 and Ghana will need to fund vaccines locally at about $50 million in four years. The NVI has signed a tech transfer agreement with PT Biopharma of Indonesia for tetanus-diphtheria vaccine manufacturing locally by 2027.
5 June 2026 · Joy Online →